Anemia of Pregnancy
Conditions
Brief summary
The main objective of this study was to compare the results of hemoglobin levels between pregnant women in the treatment group and the control group. Participants will be subjected to anthropometric measurements, recall of food intake for 1 x 24 hours, check hemoglobin before and after being given the intervention and participants in the treatment group are given moringa leaf capsules and iron tablets while participants in the control group are only given iron tablets. Researchers will compare the final results of hemoglobin levels between the treatment group and the control group
Interventions
DIETARY_SUPPLEMENTMoringa oleifera capsules
In this arm, pregnant mothers receive capsules containing 500 mg of powdered Moringa oleifera leaves which contain 13.09 mg of iron per100 gram. Dose: 2 × 2 capsules per day for 30 days
DIETARY_SUPPLEMENTiron and folic acid supplements
In this arm, pregnant mothers receive IFA tablets 2 × 1 tablet a day for 30 days. Each IFA tablet contains 400 mcg folic acid and 180 mg Ferrous Fumarate.
Sponsors
Universitas Padjadjaran
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)
Intervention model description
1 group receives capsules of powdered Moringa leaves (active comparator), and the other group receives IFA tablets as part of routine clinical care.
Eligibility
Sex/Gender
FEMALE
Age
15 Years to 50 Years
Healthy volunteers
Yes
Inclusion criteria
* Pregnant women with 2nd and 3rd trimester of pregnancy * Pregnant women with mild to moderate anemia At day 90 after treatment
Exclusion criteria
: * Hypotensive pregnant women * Pregnant women with Gemelli * Pregnant women with chronic diseases (hepatitis and HIV)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Changes in Haemoglobin (Hb) level | Day 0 and day 30 | Hb will be meassured twice, before treatment and 30 days after treatment |
Countries
Indonesia
Outcome results
None listed